What's breaking now, across thousands of outlets.
Roche will seek European approval for its promising new breast cancer pill giredestrant later than it once expected, highlighting how US drug pricing pressure may be affecting pharmaceutical companies’ launch strategies elsewhere. As recently as ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The companies said the findings suggest the treatment has a “limited” impact in HER2-low breast cancer, an area where AstraZeneca and Daiichi Sankyo’s Enhertu has already set a high bar.
New research challenges a leading explanation for the decline in overdose deaths in the United States.
New research shows that using hormone therapy with a GLP-1 during menopause may lead to greater weight loss. Tatsiana Volkava · Moment/Getty A study presented at the 2026 Annual Meeting of The…
The campaign seeks to raise awareness and improve vaccine uptake through engagements in schools, churches, mosques and other public places across the region.
The Ghana Physician Assistants Association (GPAA) has begun a free community health screening exercise at four locations in Techiman as part of its 23rd Annual General Conference.
Black patients and people with a learning disability face longer waiting times at key stages of breast cancer care, according to a nationwide study led by the University of Surrey.
